Article
Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK.
medRxiv · 2021 · Chen, Y.; Peng, C.; Tan, W.; Yu, J.; Zayas, J.; Peng, Y.; Lou, Z.; Pei, H.; Wang, L.
Key facts
| Title | Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK. |
|---|---|
| First author | Chen, Y.; Peng, C.; Tan, W.; Yu, J.; Zayas, J.; Peng, Y.; Lou, Z.; Pei, H.; Wang, L. |
| Journal | medRxiv |
| Published | Mar 10, 2021 |
| DOI | 10.1101/2021.03.09.434668 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183 and 5 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 8 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1